Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Predictive utility of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in intraductal papillary neoplasm of the bile duct.

Luvira V, Kamsa-Ard S, Pugkhem A, Luvira V, Srisuk T, Titapun A, Silsirivanit A, Wongkham S, Khuntikeo N, Pairojkul C, Bhudhisawasdi V.

Clin Exp Hepatol. 2019 Sep;5(3):250-255. doi: 10.5114/ceh.2019.87641. Epub 2019 Sep 5.

2.

Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.

Tummanatsakun D, Proungvitaya T, Roytrakul S, Limpaiboon T, Wongkham S, Wongkham C, Silsirivanit A, Somintara O, Sangkhamanon S, Proungvitaya S.

Biomolecules. 2019 Aug 26;9(9). pii: E413. doi: 10.3390/biom9090413.

3.

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model.

Saisomboon S, Kariya R, Vaeteewoottacharn K, Wongkham S, Sawanyawisuth K, Okada S.

Heliyon. 2019 May 9;5(5):e01675. doi: 10.1016/j.heliyon.2019.e01675. eCollection 2019 May.

4.

Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma.

Sanmai S, Proungvitaya T, Limpaiboon T, Chua-On D, Seubwai W, Roytrakul S, Wongkham S, Wongkham C, Somintara O, Sangkhamanon S, Proungvitaya S.

Oncol Lett. 2019 Jun;17(6):5275-5282. doi: 10.3892/ol.2019.10185. Epub 2019 Mar 22.

5.

Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.

Vaeteewoottacharn K, Pairojkul C, Kariya R, Muisuk K, Imtawil K, Chamgramol Y, Bhudhisawasdi V, Khuntikeo N, Pugkhem A, Saeseow OT, Silsirivanit A, Wongkham C, Wongkham S, Okada S.

Cells. 2019 May 23;8(5). pii: E496. doi: 10.3390/cells8050496.

6.

Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity.

Sittithumcharee G, Suppramote O, Vaeteewoottacharn K, Sirisuksakun C, Jamnongsong S, Laphanuwat P, Suntiparpluacha M, Matha A, Chusorn P, Buraphat P, Kakanaporn C, Charngkaew K, Silsirivanit A, Korphaisarn K, Limsrichamrern S, Tripatara P, Pairojkul C, Wongkham S, Sampattavanich S, Okada S, Jirawatnotai S.

Hepatology. 2019 May 11. doi: 10.1002/hep.30704. [Epub ahead of print]

PMID:
31077409
7.

Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma.

Yosudjai J, Wongkham S, Jirawatnotai S, Kaewkong W.

Biomed Rep. 2019 Mar;10(3):147-155. doi: 10.3892/br.2019.1188. Epub 2019 Jan 25.

8.

Overexpression of HexCer and LacCer containing 2-hydroxylated fatty acids in cholangiocarcinoma and the association of the increase of LacCer (d18:1-h23:0) with shorter survival of the patients.

Silsirivanit A, Phoomak C, Teeravirote K, Wattanavises S, Seubwai W, Saengboonmee C, Zhan Z, Inokuchi JI, Suzuki A, Wongkham S.

Glycoconj J. 2019 Apr;36(2):103-111. doi: 10.1007/s10719-019-09864-4. Epub 2019 Mar 19.

PMID:
30888588
9.

Blocking of methionine aminopeptidase-2 by TNP-470 induces apoptosis and increases chemosensitivity of cholangiocarcinoma.

Kidoikhammouan S, Seubwai W, Silsirivanit A, Wongkham S, Sawanyawisuth K, Wongkham C.

J Cancer Res Ther. 2019 Jan-Mar;15(1):148-152. doi: 10.4103/jcrt.JCRT_250_17.

10.

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance.

Intuyod K, Saavedra-García P, Zona S, Lai CF, Jiramongkol Y, Vaeteewoottacharn K, Pairojkul C, Yao S, Yong JS, Trakansuebkul S, Waraasawapati S, Luvira V, Wongkham S, Pinlaor S, Lam EW.

Cell Death Dis. 2018 Dec 11;9(12):1185. doi: 10.1038/s41419-018-1235-0.

11.

O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.

Phoomak C, Park D, Silsirivanit A, Sawanyawisuth K, Vaeteewoottacharn K, Detarya M, Wongkham C, Lebrilla CB, Wongkham S.

Mol Oncol. 2019 Feb;13(2):338-357. doi: 10.1002/1878-0261.12406. Epub 2019 Jan 10.

12.

Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis.

Vaeteewoottacharn K, Kariya R, Pothipan P, Fujikawa S, Pairojkul C, Waraasawapati S, Kuwahara K, Wongkham C, Wongkham S, Okada S.

Transl Oncol. 2019 Feb;12(2):217-225. doi: 10.1016/j.tranon.2018.10.007. Epub 2018 Nov 9.

13.

Membrane glycomics reveal heterogeneity and quantitative distribution of cell surface sialylation.

Park DD, Xu G, Wong M, Phoomak C, Liu M, Haigh NE, Wongkham S, Yang P, Maverakis E, Lebrilla CB.

Chem Sci. 2018 Jun 27;9(29):6271-6285. doi: 10.1039/c8sc01875h. eCollection 2018 Aug 7.

14.

An aberrantly spliced isoform of anterior gradient-2, AGR2vH promotes migration and invasion of cholangiocarcinoma cell.

Yosudjai J, Inpad C, Chomwong S, Dana P, Sawanyawisuth K, Phimsen S, Wongkham S, Jirawatnotai S, Kaewkong W.

Biomed Pharmacother. 2018 Nov;107:109-116. doi: 10.1016/j.biopha.2018.07.154. Epub 2018 Aug 4.

PMID:
30086457
15.

Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms.

Guragain D, Seubwai W, Kobayashi D, Silsinivanit A, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Wongkham S, Araki N, Cha'on U.

Cell Mol Biol (Noisy-le-grand). 2018 Jul 30;64(10):113-118.

PMID:
30084802
16.

Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.

Panya A, Thepmalee C, Sawasdee N, Sujjitjoon J, Phanthaphol N, Junking M, Wongkham S, Yenchitsomanus PT.

Cancer Immunol Immunother. 2018 Oct;67(10):1579-1588. doi: 10.1007/s00262-018-2212-2. Epub 2018 Jul 28.

PMID:
30056600
17.

O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1.

Phoomak C, Silsirivanit A, Park D, Sawanyawisuth K, Vaeteewoottacharn K, Wongkham C, Lam EW, Pairojkul C, Lebrilla CB, Wongkham S.

Oncogene. 2018 Oct;37(42):5648-5665. doi: 10.1038/s41388-018-0366-1. Epub 2018 Jun 18.

18.

Prognostic biomarkers for cholangiocarcinoma and their clinical implications.

Saengboonmee C, Sawanyawisuth K, Chamgramol Y, Wongkham S.

Expert Rev Anticancer Ther. 2018 Jun;18(6):579-592. doi: 10.1080/14737140.2018.1467760. Epub 2018 Apr 26. Review.

PMID:
29676221
19.

Etoposide radiosensitizes p53-defective cholangiocarcinoma cell lines independent of their G2 checkpoint efficacies.

Hematulin A, Meethang S, Utapom K, Wongkham S, Sagan D.

Oncol Lett. 2018 Mar;15(3):3895-3903. doi: 10.3892/ol.2018.7754. Epub 2018 Jan 9.

20.

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.

Utaijaratrasmi P, Vaeteewoottacharn K, Tsunematsu T, Jamjantra P, Wongkham S, Pairojkul C, Khuntikeo N, Ishimaru N, Sirivatanauksorn Y, Pongpaibul A, Thuwajit P, Thuwajit C, Kudo Y.

Mol Cancer. 2018 Jan 18;17(1):10. doi: 10.1186/s12943-018-0760-x.

21.

Inhibitory Effect of Aspirin on Cholangiocarcinoma Cells

Boueroy P, Aukkanimart R, Boonmars T, Sriraj P, Ratanasuwan P, Juasook A, Wonkchalee N, Vaeteewoottacharn K, Wongkham S.

Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3091-3096.

22.

Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.

Proungvitaya S, Sombattheera S, Boonsiri P, Limpaiboon T, Wongkham S, Wongkham C, Titapun A, Proungvitaya T.

Oncol Lett. 2017 Oct;14(4):4943-4948. doi: 10.3892/ol.2017.6763. Epub 2017 Aug 17.

23.

Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA.

Junking M, Grainok J, Thepmalee C, Wongkham S, Yenchitsomanus PT.

Tumour Biol. 2017 Oct;39(10):1010428317733367. doi: 10.1177/1010428317733367.

PMID:
29034817
24.

Disruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells.

Suwandittakul N, Reamtong O, Molee P, Maneewatchararangsri S, Sutherat M, Chaisri U, Wongkham S, Adisakwattana P.

Cancer Biomark. 2017 Sep 7;20(3):255-266. doi: 10.3233/CBM-170030.

PMID:
28946560
25.

High expression of CCDC25 in cholangiocarcinoma tissue samples.

Proungvitaya S, Klinthong W, Proungvitaya T, Limpaiboon T, Jearanaikoon P, Roytrakul S, Wongkham C, Nimboriboonporn A, Wongkham S.

Oncol Lett. 2017 Aug;14(2):2566-2572. doi: 10.3892/ol.2017.6446. Epub 2017 Jun 21.

26.

Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells.

Saentaweesuk W, Araki N, Vaeteewoottacharn K, Silsirivanit A, Seubwai W, Talabnin C, Muisuk K, Sripa B, Wongkham S, Okada S, Wongkham C.

Oncol Res. 2018 May 7;26(4):605-616. doi: 10.3727/096504017X15009778205068. Epub 2017 Jul 25.

PMID:
28762325
27.

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis.

Thuwajit C, Thuwajit P, Jamjantra P, Pairojkul C, Wongkham S, Bhudhisawasdi V, Ono J, Ohta S, Fujimoto K, Izuhara K.

Oncol Lett. 2017 Jul;14(1):623-634. doi: 10.3892/ol.2017.6250. Epub 2017 May 25.

28.

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Jusakul A, Cutcutache I, Yong CH, Lim JQ, Huang MN, Padmanabhan N, Nellore V, Kongpetch S, Ng AWT, Ng LM, Choo SP, Myint SS, Thanan R, Nagarajan S, Lim WK, Ng CCY, Boot A, Liu M, Ong CK, Rajasegaran V, Lie S, Lim AST, Lim TH, Tan J, Loh JL, McPherson JR, Khuntikeo N, Bhudhisawasdi V, Yongvanit P, Wongkham S, Totoki Y, Nakamura H, Arai Y, Yamasaki S, Chow PK, Chung AYF, Ooi LLPJ, Lim KH, Dima S, Duda DG, Popescu I, Broet P, Hsieh SY, Yu MC, Scarpa A, Lai J, Luo DX, Carvalho AL, Vettore AL, Rhee H, Park YN, Alexandrov LB, Gordân R, Rozen SG, Shibata T, Pairojkul C, Teh BT, Tan P.

Cancer Discov. 2017 Oct;7(10):1116-1135. doi: 10.1158/2159-8290.CD-17-0368. Epub 2017 Jun 30.

29.

Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways.

Puthdee N, Seubwai W, Vaeteewoottacharn K, Boonmars T, Cha'on U, Phoomak C, Wongkham S.

Biol Pharm Bull. 2017;40(6):751-757. doi: 10.1248/bpb.b16-00428.

30.

Repurposing cimetidine for cholangiocarcinoma: Antitumor effects in vitro and in vivo.

Dana P, Vaeteewoottacharn K, Kariya R, Matsuda K, Wongkham S, Okada S.

Oncol Lett. 2017 Mar;13(3):1432-1436. doi: 10.3892/ol.2017.5563. Epub 2017 Jan 2.

31.

In Vitro and In Vivo Inhibitory Effects of α-Mangostin on Cholangiocarcinoma Cells and Allografts

Aukkanimart R, Boonmars T, Sriraj P, Sripan P, Songsri J, Ratanasuwan P, Laummaunwai P, Boueroy P, Khueangchaingkhwang S, Pumhirunroj B, Artchayasawat A, Boonjaraspinyo S, Wu Zh, Hahnvajanawong Ch, Vaeteewoottacharn K, Wongkham S.

Asian Pac J Cancer Prev. 2017 Mar 1;18(3):707-713.

32.

High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation.

Phoomak C, Vaeteewoottacharn K, Silsirivanit A, Saengboonmee C, Seubwai W, Sawanyawisuth K, Wongkham C, Wongkham S.

Sci Rep. 2017 Mar 6;7:43842. doi: 10.1038/srep43842.

33.

Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process.

Dana P, Kariya R, Vaeteewoottacharn K, Sawanyawisuth K, Seubwai W, Matsuda K, Okada S, Wongkham S.

Oncol Res. 2017 Aug 7;25(7):1047-1059. doi: 10.3727/096504016X14813899000565. Epub 2016 Dec 15.

PMID:
28244853
34.

Targeting hexokinase II as a possible therapy for cholangiocarcinoma.

Thamrongwaranggoon U, Seubwai W, Phoomak C, Sangkhamanon S, Cha'on U, Boonmars T, Wongkham S.

Biochem Biophys Res Commun. 2017 Mar 4;484(2):409-415. doi: 10.1016/j.bbrc.2017.01.139. Epub 2017 Jan 25.

PMID:
28131825
35.

Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.

Saengboonmee C, Seubwai W, Cha'on U, Sawanyawisuth K, Wongkham S, Wongkham C.

Anticancer Res. 2017 Jan;37(1):115-123.

PMID:
28011481
36.

Novel Synthetic Mono-triazole Glycosides Induce G0/G1 Cell-cycle Arrest and Apoptosis in Cholangiocarcinoma Cells.

Obchoei S, Saeeng R, Wongkham C, Wongkham S.

Anticancer Res. 2016 Nov;36(11):5965-5973.

PMID:
27793922
37.

High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.

Chua-On D, Proungvitaya T, Techasen A, Limpaiboon T, Roytrakul S, Wongkham S, Wongkham C, Somintara O, Sungkhamanon S, Proungvitaya S.

Tumour Biol. 2016 Oct;37(10):13659-13667. Epub 2016 Jul 29.

PMID:
27473083
38.

Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.

Uthaisar K, Vaeteewoottacharn K, Seubwai W, Talabnin C, Sawanyawisuth K, Obchoei S, Kraiklang R, Okada S, Wongkham S.

Oncol Rep. 2016 Sep;36(3):1435-46. doi: 10.3892/or.2016.4974. Epub 2016 Jul 25.

PMID:
27461717
39.

Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.

Chng KR, Chan SH, Ng AHQ, Li C, Jusakul A, Bertrand D, Wilm A, Choo SP, Tan DMY, Lim KH, Soetinko R, Ong CK, Duda DG, Dima S, Popescu I, Wongkham C, Feng Z, Yeoh KG, Teh BT, Yongvanit P, Wongkham S, Bhudhisawasdi V, Khuntikeo N, Tan P, Pairojkul C, Ngeow J, Nagarajan N.

EBioMedicine. 2016 Jun;8:195-202. doi: 10.1016/j.ebiom.2016.04.034. Epub 2016 May 6.

40.

Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.

Phoomak C, Vaeteewoottacharn K, Sawanyawisuth K, Seubwai W, Wongkham C, Silsirivanit A, Wongkham S.

Sci Rep. 2016 Jun 13;6:27853. doi: 10.1038/srep27853.

41.

 Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.

Sribenja S, Natthasirikul N, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Jearanaikoon P, Wongkham S.

Ann Hepatol. 2016 Jul-Aug;15(4):577-85.

42.

Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.

Talabnin C, Janthavon P, Thongsom S, Suginta W, Talabnin K, Wongkham S.

Hum Pathol. 2016 Jun;52:47-54. doi: 10.1016/j.humpath.2015.12.027. Epub 2016 Feb 1.

PMID:
26980022
43.

Differential Expression of O-glycoprotein Glycans in Cholangiocarcinoma Cell Lines.

Talabnin K, Talabnin C, Ishihara M, Azadi P, Wongkham S, Sripa B.

Asian Pac J Cancer Prev. 2016;17(2):691-5.

44.

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.

Seubwai W, Vaeteewoottacharn K, Kraiklang R, Umezawa K, Okada S, Wongkham S.

Oncol Res. 2016;23(1-2):21-8. doi: 10.3727/096504015X14424348426071.

PMID:
26802647
45.

Genomics of worms, with an emphasis on Opisthorchis viverrini - opportunities for fundamental discovery and biomedical outcomes.

Gasser RB, Tan P, Teh BT, Wongkham S, Young ND.

Parasitol Int. 2017 Aug;66(4):341-345. doi: 10.1016/j.parint.2016.01.005. Epub 2016 Jan 12. Review.

PMID:
26792076
46.

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.

Seubwai W, Vaeteewoottacharn K, Kraiklang R, Umezawa K, Okada S, Wongkham S.

Oncol Res. 2016 Jan 21;23(1):21-28. doi: 10.3727/096504015X14424348426071.

PMID:
29021017
47.

YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.

Thongsom S, Chaocharoen W, Silsirivanit A, Wongkham S, Sripa B, Choe H, Suginta W, Talabnin C.

Tumour Biol. 2016 Jul;37(7):9451-63. doi: 10.1007/s13277-016-4838-z. Epub 2016 Jan 19.

PMID:
26781979
48.

Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.

Vaeteewoottacharn K, Kariya R, Dana P, Fujikawa S, Matsuda K, Ohkuma K, Kudo E, Kraiklang R, Wongkham C, Wongkham S, Okada S.

Tumour Biol. 2016 Jul;37(7):9023-35. doi: 10.1007/s13277-016-4785-8. Epub 2016 Jan 13.

PMID:
26762407
49.

High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.

Saengboonmee C, Seubwai W, Pairojkul C, Wongkham S.

Sci Rep. 2016 Jan 8;6:18995. doi: 10.1038/srep18995.

50.

Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.

Sribenja S, Natthasirikul N, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Jearanaikoon P, Wongkham S.

Ann Hepatol. 2016 Jul - Aug;15(4):577-585. doi: 10.5604/16652681.1203155.

Supplemental Content

Loading ...
Support Center